Skip to content

Antiretroviral adherence in resource-poor settings: Challenging the voices of doom

In the eye of the provider: Directly observed HIV therapy

Herpes virus shedding increases HIV infectivity too

South African survey lifts lid off HIV epidemic, shows progress on prevention

Gilead acquires Triangle, will push for tenofovir and FTC in one tablet

Business Coalition aims for HIV programmes as corporate norm

Men with metabolic syndrome around three times more likely to die of heart disease

How long can HIV treatment be spared once the CD4 count falls below 350?

New single tablet version of efavirenz now available in UK